MyWay Digital Health secures £3m from Foresight Group to accelerate product development and expand globally.
The investment was led by Foresight Group to support the company in scaling its digital healthcare solutions.
MyWay Digital Health provides data-driven technology and platforms to help manage chronic conditions like diabetes. The company operates from offices in Dundee, Edinburgh, and London.
Edinburgh-based digital healthcare provider MyWay Digital Health has secured £3m in funding from Foresight Group. The capital will be used to accelerate product development and support commercial expansion in domestic and international markets.
Founded as a spin-out from the University of Dundee, the company offers digital self-management tools integrated with NHS systems. Alongside the investment, Dr Umang Patel has been appointed as Non-Executive Chair to guide the firm through its next phase of growth.
From the founder
"We are delighted to have secured investment from Foresight, marking a significant milestone in MWDH’s journey. Their support will enable us to accelerate our growth strategy, broaden our product offering, and further expand our global footprint."
Debbie Wake
CEO and Co-Founder at MyWay Digital Health
Investor perspective
"The adoption of digital tools and AI to reduce the burden on frontline care is critical. MWDH is at the forefront of this and its best in class technology is proven to deliver better health outcomes and cost savings for its customers. Foresight is excited to support the team on their next phase of growth."
Daniel Halliday
Managing Director, Foresight Group
Use of funds
- 01Continue product development
- 02Expand into international markets
Investors
Categories
About the company
MyWay Digital Health
MyWay Digital Health develops data-driven digital health platforms for chronic condition management.